Changes in Expression of the Albumin, Fibronectin and Type I Procollagen Genes in CCl4-Induced Liver Fibrosis: Effect of Pyridoxol L,2-Pyrrolidon-5 Carboxylate-Reference-Cited by-同舟云学术

Changes in Expression of the Albumin, Fibronectin and Type I Procollagen Genes in CCl4-Induced Liver Fibrosis: Effect of Pyridoxol L,2-Pyrrolidon-5 Carboxylate

Published:1993-12 Issue:6 Volume:73 Page:301-304
ISSN:0901-9928
Container-title:Pharmacology & Toxicology
language:en
Short-container-title:

Author:

Arosio B.,Santambrogio D.,Gagliano N.,Annoni G.

Publisher

Wiley

Subject

Health, Toxicology and Mutagenesis,Pharmacology,Toxicology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0773.1993.tb01355.x/fullpdf

Reference17 articles.

1. Albumin and collagen gene regulation in alcohol and virus-induced human liver disease;Annoni;Gastroenterology,1990

2. Pyridoxol L,2-pyrrolidon-5 carboxilate prevents active fibroplasia in CCl4-treated rats;Annoni;Pharmacol. Res.,1992

3. Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction;Chomczynski;Analyt. Biochem.,1987

4. In vitro and in vivo association of transforming growth factor-B 1 with hepatic fibrosis;Czaja;J. Cell. Biol.,1989

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Metadoxine on Chronic Primary Hepatopathies in Canines: Number of Cases;Revista MVZ Córdoba;2023-09-01

2. Anluohuaxianwan alleviates carbon tetrachloride-induced hepatic fibrosis in rats through upregulation of peroxisome proliferator-activated receptor-gamma and downregulation of nuclear factor-kappa B/IκBα signaling pathway;World Journal of Traditional Chinese Medicine;2019

3. Pharmacology, Systematic Review and Recent Clinical Trials of Metadoxine;Reviews on Recent Clinical Trials;2018-05-07

4. Anti-Fibrotic Therapies from Other Organs: What the Gut Can Learn from the Liver, Skin, Lung and Heart;Fibrostenotic Inflammatory Bowel Disease;2018

5. Molecular antagonists, leptin or other hormones in supplementing environmental factors?;Clinical Dilemmas in Non-Alcoholic Fatty Liver Disease;2016-02-19